寻求治疗的盆腔器官脱垂女性下尿路症状的自然史:下尿路功能障碍症状研究网络(LURN)
本研究基于LURN观察性队列中371例有12个月随访数据的女性,评估盆腔器官脱垂与下尿路症状的基线关联及12个月纵向变化。脱垂组58例(16%)基线LURN总严重度评分低于无脱垂组(38.9±14.0 vs 43.2±14.0;P=.036),所有尿路症状结局在3和12个月均较基线改善(P<.05),脱垂状态与症状变化无显著交互作用。
要点
- 脱垂组基线LURN总严重度评分低于无脱垂组(38.9±14.0 vs 43.2±14.0;P=.036)。
- 所有尿路症状结局在3和12个月均较基线改善(P<.05),与脱垂状态无关。
- 梗阻严重度评分与POP-Q Ba、Bp及阴道最大下降点呈正相关。
核心结论
- 在寻求治疗的尿路症状女性中,梗阻症状与脱垂呈正相关,而总体下尿路症状严重度与脱垂呈负相关。
- 无论脱垂状态如何(包括治疗脱垂、未治疗脱垂及无脱垂者),LURN评分在12个月内均改善。
研究设计与样本
- 纳入LURN观察性队列研究中具有充分12个月随访数据的女性,共分析371例,其中无脱垂313例(84%),脱垂58例(16%)。
- 脱垂定义为POP-Q Ba、C或Bp点>0(超过处女膜)。
- 随访期间脱垂及下尿路症状治疗按标准诊疗进行。
- 采用混合效应模型,对患者斜率和截距设随机效应,并调整其他协变量。
- 研究对较少见组间比较(如脱垂 vs 无脱垂)检测0.4个标准差差异的把握度>90%。
主要发现
- 脱垂组较无脱垂组年龄更大(64.6±8.8 vs 55.3±14.1岁;P<.001)。
- 脱垂组较无脱垂组更可能接受脱垂手术(28% vs 1%;P<.001)和子宫托治疗(26% vs 4%;P<.001)。
- 脱垂组基线LURN总严重度评分低于无脱垂组(38.9±14.0 vs 43.2±14.0;P=.036),其他量表平均评分无组间差异。
- 所有尿路结局的平均评分在3和12个月均较基线显著降低(改善)(均P<.05)。
- 混合效应模型中,脱垂测量与访视、时间依赖性脱垂治疗组之间均无统计学显著交互作用(所有回归交互系数P>.05)。
关键数值与推荐
- LURN梗阻严重度评分与POP-Q Ba、Bp及阴道最大下降点呈统计学显著正相关。
- LURN总严重度量表与POP-Q Ba及阴道最大下降点呈统计学显著负相关。
- 其他脱垂与下尿路症状的关联均不显著(所有回归系数P>.05)。
- 脱垂组间症状差异较小:所有回归系数(可解释为各评分的加性百分比变化)在-5至5之间(结局标准差范围为14.0-32.4)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association of pelvic organ prolapse with overactive bladder and other lower urinary tract symptoms, and the natural history of those symptoms are not well characterized. Previous cross-sectional studies demonstrated conflicting relationships between prolapse and lower urinary tract symptoms. OBJECTIVE: This study primarily aimed to determine the baseline association between lower urinary tract symptoms and prolapse and to assess longitudinal differences in symptoms over 12 months in women with and without prolapse. Secondary aims were to explore associations between lower urinary tract symptoms and prolapse treatment. We hypothesized that: (1) prolapse is associated with the presence of lower urinary tract symptoms, (2) lower urinary tract symptoms are stable over time in patients with and without prolapse, and (3) prolapse treatment is associated with lower urinary tract symptom improvement. STUDY DESIGN: Women enrolled in the Symptoms of Lower Urinary Tract Dysfunction Research Network Observational Cohort Study with adequate 12-month follow-up data were included. Prolapse and lower urinary tract symptom treatment during follow-up was guided by standard of care. Outcome measures included the Lower Urinary Tract Symptoms Tool total severity score (in addition to overactive bladder, obstructive, and stress urinary incontinence subscales) and Urogenital Distress Inventory-6 Short Form. Prolapse (yes or no) was defined primarily when Pelvic Organ Prolapse Quantification System points Ba, C or Bp were >0 (beyond the hymen). Mixed-effects models with random effects for patient slopes and intercepts were fitted for each lower urinary tract symptom outcome and prolapse predictor, adjusted for other covariates. The study had >90% power to detect differences as small as 0.4 standard deviation for less prevalent group comparisons (eg, prolapse vs not). RESULTS: A total of 371 women were analyzed, including 313 (84%) with no prolapse and 58 (16%) with prolapse. Women with prolapse were older (64.6±8.8 vs 55.3±14.1 years; P<.001) and more likely to have prolapse surgery (28% vs 1%; P<.001) and pessary treatment (26% vs 4%; P<.001) during the study. Average baseline Lower Urinary Tract Symptoms Tool total severity scores were lower (fewer symptoms) for participants with prolapse compared with those without (38.9±14.0 vs 43.2±14.0; P=.036), but there were no differences in average scores between prolapse groups for other scales. For all urinary outcomes, average scores were significantly lower (improved) at 3 and 12 months compared with baseline (all P<.05). In mixed-effects models, there were no statistically significant interactions between pelvic organ prolapse measurement and visit and time-dependent prolapse treatment groups (P>.05 for all regression interaction coefficients). The Lower Urinary Tract Symptoms Tool obstructive severity score had a statistically significant positive association with Pelvic Organ Prolapse Quantification System Ba, Bp, and point of maximum vaginal descent. The Lower Urinary Tract Symptoms Tool total severity scale had a statistically significant negative association with Pelvic Organ Prolapse Quantification System Ba and point of maximum vaginal descent. No other associations between prolapse and lower urinary tract symptoms were significant (P>.05 for all regression coefficients). Symptom differences between prolapse groups were small: all regression coefficients (interpretable as additive percentage change in each score) were between -5 and 5 (standard deviation of outcomes ranged from 14.0-32.4). CONCLUSION: Among treatment-seeking women with urinary symptoms, obstructive symptoms were positively associated with prolapse, and overall lower urinary tract symptom severity was negatively associated with prolapse. Lower Urinary Tract Symptoms Tool scores improved over 12 months regardless of prolapse status, including in those with treated prolapse, untreated prolapse, and without prolapse.
引用
- Kowalski JT, Wiseman JB, Smith AR, et al. Natural history of lower urinary tract symptoms in treatment-seeking women with pelvic organ prolapse; the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). Am J Obstet Gynecol. 2022. PMID: 35934118. doi:10.1016/j.ajog.2022.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。